APPLICATION
ANDA213637
TYPE
ANDA
ORIGINAL APPROVAL
2024-12-09
LATEST ACTION
2024-12-09
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
IOBENGUANE I-123Discontinued
IOBENGUANE SULFATE I-123 10mCi/5ML (2mCi/ML) · SOLUTION · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.